BSEBoard Meeting2d ago · 5 Nov 2026, 11:02 am

Centenial Surgical Suture Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2026 ,inter alia, to consider and approve 1. To approve Standalone Un-Audited Financial Results for the quarter & half year ended on September 30, 2026, pursuant to Regulation 33 of SEBI (LODR) Regulation, 2015. 2. To consider the proposal for raising of funds by way of equity shares or any other securities through permissible ....

Centenial Surgical Suture Ltd · 531380

✦ AI SummaryResults

Centenial Surgical Suture Ltd has scheduled a board meeting on November 12, 2026, to consider and approve standalone un-audited financial results for the quarter and half year ended September 30, 2026, and to consider a proposal for raising funds through equity shares or other securities.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Centenial Surgical Suture Ltd - 531380 - Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2026 Pursuant To Regulation 29 Read With Regulation 33 Of SEBI (LODR) Regulation, 2015

Attachments (1)

📄

da870e45-64e5-436b-b896-37f635274f56.pdf

pdf

Download →
View document text
9001:2015 | 13485:2016 | 14001:2015 45001:2018 G.M.P. CIN: L99999MH1995PLCO8 Regd Office - 1-29, MIDC, Murbad, Thane 421401, MAHAR? E: admin@centenialindia.com @ Thursday, November 5, 2026 Not s Department of Corporate Service BSE Limited, Registered Office : Floor 254P. J. Towers, . Dalal Street, Fort, Mumbai 400001. MAHARASHTRA. T: 2272 1233/ 1234 | F: 2272 3121/ 3719 | www.bseindia.com Subject : Intimation of Board Meeting as per Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements [LODR]) Regulations, 2015 for approval of Standalone Un-Audited Financial Results for the quarter and half year ended September 30, 2026 as per Regulation 33 of the SEBI (LODR) Regulations, 2015. Reference : CENTENIAL SURGICAL SUTURE LTD. | Scrip Code: 531380 Sir, We hereby inform you that pursuant to Regulation 29 read with Regulation 33 of SEBI (LODR) Regulation, 2015, the meeting of Board of Directors of the Company CENTENIAL SURGICAL SUTURE LTD. will be held on Thursday November 12, 2026, to transact the following business: 1. To approve Standalone Un-Audited Financial Results for the quarter & half year ended on September 30, 2026, pursuant to Regulation 33 of SEBI (LODR) Regulation, 2015. 2. To consider the proposal for raising of funds by way of equity shares or any other securities through permissible modes, including but not limited to a rights issue or preferential issue or qualified institutions placement or any other method or a combination thereof, as may be permitted under applicable laws including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 and the Companies Act, 2013, as amended, and subject to receipt of regulatory / statutory / necessary approvals, as may be required. 3. Any other business with the permission of chair. The approved results will be uploaded on BSE Limited website after conclusion of the said meeting. In compliance with Code of Conduct to regulate, monitor and report trading in Securities of the Company, please note that the Trading Window for dealing in securities of the Company has already been closed with effect from October 1, 2026, and shall continue to remain closed till November 14, 2026 (inclusive). Sincerely, For CENTENIAL SURGICAL SUTURE LTD. Ma hima' Digitally signedby | Mahima Bathwal /1 / Da 026.11.05 BathWal Tosee 10530 Mahima BATHWAL Membership No. ACS A35069 Company Secretary & Compliance Officer I Registered Office M salesOf fice - Kolkata Sound oo, 385, R, S Kasha MW | Kolata 700076, WEST BENGAL Qo0 Fxonzi66] | 9 IMBHETS 1) 33885